I am a
Home I AM A Search Login

Papers of the Week

2021 Jun

Explor Res Clin Soc Pharm


Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study.


Park T, Bresnahan M, Griggs SK, Chen J, Cho AH, Gousse Y, Feinglos M
Explor Res Clin Soc Pharm. 2021 Jun; 2:100022.
PMID: 35481118.


The effects of dipeptidyl peptidase-4 inhibitors (DPP4Is) on joint pain have been controversial.